Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Carcinoma × Clear all

Phase

Phase 2 24 Phase NA 10 Phase 1 9 Phase 1/2 8 Phase 3 7 Phase EARLY_PHASE1 2 Phase 2/3 2 Phase 4 1

Status

Completed 11 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Carcinoma, Hepatocellular 40 Neoplasms 39 Polycystic Ovary Syndrome 27 Colorectal Neoplasms 24 Stomach Neoplasms 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Carcinoma, Non-Small-Cell Lung 16 Prostatic Neoplasms 15 Recurrence 13 Pancreatic Neoplasms 13 Lymphoma 12 Liver Neoplasms 12 Leukemia, Myeloid, Acute 11 Esophageal Neoplasms 11 Urinary Bladder Neoplasms 10 Leiomyoma 10 Colonic Neoplasms 10 Pain 9 Lung Neoplasms 9 Uterine Cervical Neoplasms 7 Neoplasm Metastasis 7 Multiple Myeloma 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Follicular 7 Keratosis, Actinic 7 Infertility 7 Papillomavirus Infections 6 Pain, Postoperative 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

elemene 1 aumolertinib 1 aflutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Unknown

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡